HighMark Wealth Management LLC
- SEC CIK
- 0001802451
- Latest filing
- Aug 12, 2026
ZNTL holding history
Zentalis Pharmaceuticals, Inc. in every 13F filed by HighMark Wealth Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings
- Shares (Q2 2026)
- 130
- Value
- $630
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 130 | $630 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 130 | $304 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 130 | $175 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 130 | $196 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 130 | $151 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 130 | $207 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 130 | $394 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 130 | $478 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 130 | $532 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 130 | $2.05K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 130 | $1.97K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 130 | $2.61K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 130 | $3.67K | <0.1% | +130 | New | Holders |